Log In
BCIQ
Print this Print this
 

Secrelux

  Manage Alerts
Collapse Summary General Information
Company Sanochemia Pharmazeutika AG
DescriptionX-ray imaging agent
Molecular Target
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPancreas cancer, Diagnostic
Regulatory Designation
PartnerLink Healthcare

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$149.4M

$34.5M

$85.1M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/30/2015

$149.4M

$34.5M

$85.1M

Get a free BioCentury trial today